摘要
Abstract
Objective:To analyze the application effect of Terbutaline combined with Azithromycin sequential therapy in the treatment of Mycoplasma pneumoniae pneumonia(MPP)in children.Method:A total of 120 children with MPP who admitted to Jinjiang City Hospital from January 2023 to February 2024 were selected,they were randomly divided into group A(n=60)and group B(n=60).Group A was given Azithromycin sequential therapy,group B was given Terbutaline combined with Azithromycin sequential therapy,the regression time of symptoms and signs,serum inflammatory factor levels,clinical efficacy and adverse reactions were compared between two groups.Result:The disappearance times of fever,wheezing,cough and pulmonary rales in group B were earlier than those in group A,and the differences were statistically significant(P<0.05).After treatment,the levels of serum C-reactive protein,tumor necrosis factor-α and interleukin-6 in two groups were lower than those before treatment,and those in group B were lower than those in group A,the differences were statistically significant(P<0.05).The total effective rate and total effective rate of group B were higher than those of group A,and the differences were statistically significant(P<0.05).There was no significant difference in the total incidence of adverse reactions between two groups(P>0.05).Conclusion:Terbutaline combined with Azithromycin sequential therapy is effective and safe in the treatment of MPP in children.关键词
肺炎支原体肺炎/阿奇霉素序贯疗法/特布他林/效果/安全性Key words
Mycoplasma pneumoniae pneumonia/Azithromycin sequential therapy/Terbutaline/Effect/Safety
